Xiong Wei-Hong, Brown R Lane, Reed Brian, Burke Neal S, Duvoisin Robert M, Morgans Catherine W
Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, Oregon, United States.
Department of Integrative Physiology and Neuroscience, Washington State University, Pullman, Washington, United States.
Invest Ophthalmol Vis Sci. 2015 Feb 3;56(2):1367-73. doi: 10.1167/iovs.14-15270.
Administration of voriconazole, an antifungal triazole, causes transient visual disturbances in patients and attenuates the b-wave of the ERG. We sought to identify the retinal target of voriconazole underlying the effect on the ERG b-wave.
Electroretinograms were recorded from mice before and after intraperitoneal injection of voriconazole. The effect of voriconazole on ON-bipolar cells was tested by patch-clamp recordings of ON-bipolar cells in mouse retinal slices. Effects of voriconazole on mGluR6 and TRPM3 were assessed by patch-clamp recordings of Chinese hamster ovary (CHO) and HEK293 cells transfected with either TRPM3 or mGluR6 plus Kir3.1/Kir3.4.
Voriconazole attenuated the ERG b-wave in mice, and inhibited ON-bipolar cell responses evoked by application of CPPG, an mGluR6 antagonist, onto the ON-bipolar cell dendrites, indicating that voriconazole blocks a step in the mGluR6-TRPM1 signal transduction pathway. Voriconazole almost completely blocked capsaicin-activated currents in ON-bipolar cells, which have been attributed to direct activation of the TRPM1 cation channel. Furthermore, application of voriconazole to CHO cells expressing TRPM3, a closely related channel to TRPM1, showed that voriconazole reversibly blocked pregnenolone sulfate-stimulated TRPM3 currents in transfected cells. In contrast, voriconazole only slightly inhibited mGluR6-mediated activation of G-protein activated inward rectifier potassium (GIRK) currents in cotransfected cells, suggesting that mGluR6 is not the primary target of voriconazole in ON-bipolar cells.
The visual disturbances associated with voriconazole are likely due to block of TRPM1 channels in retinal ON-bipolar cells. Other neurological effects of voriconazole may be due to block of TRPM3 channels expressed in the brain.
抗真菌三唑类药物伏立康唑的使用会导致患者出现短暂的视觉障碍,并减弱视网膜电图(ERG)的b波。我们试图确定伏立康唑对ERG b波产生影响的视网膜靶点。
在小鼠腹腔注射伏立康唑前后记录视网膜电图。通过对小鼠视网膜切片中ON双极细胞进行膜片钳记录来测试伏立康唑对ON双极细胞的作用。通过对转染了TRPM3或mGluR6加Kir3.1/Kir3.4的中国仓鼠卵巢(CHO)细胞和HEK293细胞进行膜片钳记录,评估伏立康唑对mGluR6和TRPM3的影响。
伏立康唑减弱了小鼠的ERG b波,并抑制了将mGluR6拮抗剂CPPG应用于ON双极细胞树突时诱发的ON双极细胞反应,这表明伏立康唑阻断了mGluR6 - TRPM1信号转导通路中的一个步骤。伏立康唑几乎完全阻断了ON双极细胞中辣椒素激活的电流,该电流被认为是由TRPM1阳离子通道的直接激活引起的。此外,将伏立康唑应用于表达与TRPM1密切相关的通道TRPM3的CHO细胞,结果显示伏立康唑可逆地阻断了转染细胞中硫酸孕烯醇酮刺激的TRPM3电流。相比之下,伏立康唑仅轻微抑制共转染细胞中mGluR6介导的G蛋白激活内向整流钾(GIRK)电流,这表明mGluR6不是伏立康唑在ON双极细胞中的主要靶点。
与伏立康唑相关的视觉障碍可能是由于视网膜ON双极细胞中的TRPM1通道被阻断。伏立康唑的其他神经学效应可能是由于大脑中表达的TRPM3通道被阻断。